Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.

Authors

Vivien Wai Yun Lai, Dylan Hansen, Maryam Tabesh, Jessica Fairley, Laura Ross, Nava Ferdowsi, Gene-Siew Ngian, Diane Apostolopoulos, Joanne Sahhar, Lauren V Host, Jennifer Walker, Gabor Major, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Amanda M Saracino

Published in

The Australasian journal of dermatology. Jul 06, 2026. Epub Jul 06, 2026.

Abstract

This Australian retrospective cohort analysis of 1977 patients investigates and expands on correlates of telangiectasia in systemic sclerosis to determine whether this cutaneous sign is a potential surrogate marker for disease progression and prognosis. We found that pulmonary arterial hypertension and digital ulcers were significant correlates of telangiectasia, which was also an independent risk factor for mortality. Careful monitoring of telangiectasia may provide an indicator for more severe vasculopathy, with increased morbidity and mortality in systemic sclerosis.

PMID:
42410945
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.